Search results
V. A. Shiva Ayyadurai (born Vellayappa Ayyadurai Shiva on December 2, 1963) is an Indian-American engineer, politician, entrepreneur, and anti-vaccine activist. He has become known for promoting conspiracy theories, pseudoscience, and unfounded medical claims.
Dr.SHIVA Ayyadurai, the Inventor of Email, Scientist, Innovator, Educator, holds four degrees from M.I.T., is a Fulbright Scholar, Lemelson-MIT Awards Finalist and Westinghouse Science Talent ...
Dr. Shiva Ayyadurai, MIT PhD, the Inventor of Email, world-renowned scientist and engineer, holds 4 degrees from MIT, is a Fulbright Scholar, started 7 successful hi-tech companies, and is the founder of the international movement for Truth Freedom Health(R).
Beyond the invention of email in 1978, Dr. V.A. Shiva Ayyadurai, who holds four degrees from MIT, is a Fullbright Scholar, MIT-Lemelson Awards Finalist and Westinghouse Science Talent Search Honors Award recipient, has continued his work as both an inventor and systems scientist across a broad range of fields from media to medicine, art and ...
Dr. Shiva Ayyadurai, MIT PhD, the Inventor of Email, Candidate for U.S. President, and… · Experience: Shiva4President.com · Education: Massachusetts Institute of Technology · Location ...
- Shiva4President.com
Dr. V.A. Shiva Ayyadurai, the inventor of email and polymath, holds four degrees from MIT, is a world-renowned systems scientist, inventor and entrepreneur.
Dec 3, 2021 · Shiva Ayyadurai, an MIT lecturer who’s decried the COVID-19 vaccines and spewed election fraud conspiracy theories, announced his bid for Massachusetts governor in a...
Feb 22, 2012 · A groundbreaking early email program, written by a high school student in 1979, helps tell the story of this crucial technology’s history. Joseph Stromberg. February 22, 2012. Shiva...
Jun 13, 2017 · Shiva Ayyadurai understands this. Ayyadurai has spent nearly six years publicly proclaiming himself the “inventor of e-mail.” But this claim about e-mail—as everyone but Ayyadurai’s...
Shiva is the Chairman & CEO of CytoSolve Inc., which provides a revolutionary platform for modeling complex diseases and developing multi-combination therapeutics.
